The Biomedical Informatics program enables researchers to find collaborators and resources that match their needs and interests; study populations across multiple Harvard University affiliates; receive state-of-the-art education in the use of computational tools; and increase the cohesion of our research community across multiple institutional boundaries.
The Biostatistics program supports Harvard University clinical and translational investigators. Drawing on a team of highly skilled biostatisticians from our academic and hospital community, the program offers consultations on a range of topics as well as software tools to researchers as they design new studies.
The Child Health Committee works to foster the development of programs, resources, and strategies that support innovative and collaborative research to improve the health and wellbeing of children. The committee works across Harvard University, its affiliated institutions, and the national Clinical and Translational Science Award (CTSA) Consortium, a network of centers funding by the National Center for Advancing Translational Sciences (NCATS).
The goal of the C/T Research Academy is to support, nurture, and grow the next generation of C/T investigators at Harvard Medical School.
The Community Engagement program seeks to increase the pace of adoption of evidence-based programs and policies to promote health, prevent disease, and eliminate disparities.
The Connector program links and supports clinical investigators across all of Harvard University’s schools and affiliated hospitals to promote the formation of clinical and translational research teams and facilitate high-quality research.
The Diversity Inclusion program supports institutional efforts to increase diversity among Harvard Medical School faculty and trainees through fellowships, education, mentoring, and community-building events aimed at improving the promotion and retention rates among diverse faculty who are conducting clinical and translational research.
The KL2/Catalyst Medical Research Investigator Training (CMeRIT) program provides advanced training in clinical and translational research to senior fellows and junior faculty from all health professions represented by Harvard Catalyst, including medicine, dentistry, and nursing.
The principal focus of the Leder Human Biology & Translational Medicine (LHB) program is on the training of graduate students who are interested in careers in translational research. This program provides the organizational, curricular, and intellectual infrastructure for creating a community of students and faculty interested in disease-oriented research and in the translation of principles of human biology and disease mechanisms to clinical applications. Students need not undertake thesis work in this area, but must be interested in future work in this domain.
The Postgraduate Education program, in collaboration with Harvard-affiliated institutions, offers a full range of courses, workshops, and learning opportunities for the research community, as well as customized training throughout their careers.
The Regulatory Foundations, Ethics, and Law program serves as a resource to the research community to help minimize regulatory burdens while ensuring that research is conducted with the highest standards of scientific design.
Translational Innovator leverages partnerships and collaborations within and outside of Harvard University to evaluate–and ultimately, improve—the conduct of research.
Related Programs & Initiatives
Launched in 2014, the Football Players Health Study is a comprehensive research program at Harvard University dedicated to addressing the health and wellbeing of former NFL players. It is the largest study ever conducted of living former players. Harnessing the expertise of the University’s faculty and researchers across interdisciplinary domains, including neurology, sports medicine, rehabilitation medicine, public health, cardiology, and more, the Study is the first to advance our knowledge of the inter-dependency of the multiple, and often interrelated, conditions that former players face.
SMART IRB (the Streamlined, Multisite, Accelerated Resources for Trials IRB Reliance platform) is designed to harmonize and streamline the IRB review process for multisite studies, while ensuring a high level of protection for research participants.